Tinnitus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The Tinnitus pipeline market report provides a comprehensive overview of the therapeutics under development for Tinnitus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Tinnitus and features dormant and discontinued projects.
Tinnitus Pipeline Drugs Market by Key Targets
In the Tinnitus pipeline drugs market, the key targets are Potassium Voltage Gated Channel Subfamily KQT Member 2, Potassium Voltage Gated Channel Subfamily KQT Member 3, Glutamate Ionotropic Receptor NMDA Type Subunit, Calcium Activated Potassium Channel, Neurotrophic Factor, and Voltage Dependent L Type Calcium Channel.
Key Targets in the Tinnitus Pipeline Drugs Market
For more target insights, download a free report sample
Key MoA in the Tinnitus Pipeline Drugs Market
Potassium Voltage Gated Channel Subfamily KQT Member 2 Activator has the highest share in the Tinnitus pipeline drugs market. The other key mechanisms of action are Potassium Voltage Gated Channel Subfamily KQT Member 3 Activator, Glutamate Ionotropic Receptor NMDA Type Subunit Antagonist, Neurotrophic Factor Activator, and Voltage Dependent L Type Calcium Channel Blocker.
Tinnitus Pipeline Drugs Market Analysis, by MoA
To get more insights on key MoA, download a free sample report
Tinnitus Pipeline Drugs Market Segmentation by RoA
The key routes of administration in the Tinnitus pipeline drug market are intratympanic, oral, and topical. Intratympanic has the maximum number of pipeline products.
Tinnitus Pipeline Drugs Market Analysis, by RoA
To get more insights on key RoA, download a free sample report
Key Molecule Types in the Tinnitus Pipeline Drugs Market
The key molecule type in the Tinnitus pipeline drugs market is small molecule.
Major Companies in the Tinnitus Pipeline Drugs Market
Some of the major companies in the Tinnitus pipeline drugs market are Gateway Biotechnology Inc, Altamira Therapeutics Ltd, AudioCure Pharma GmbH, Cognosetta Inc, Knopp Biosciences LLC, Otonomy Inc, and Sensorion SA.
Tinnitus Pipeline Drugs Market, by Major Companies
For more company insights, download a free sample report
Tinnitus Pipeline Drugs Market Overview
Key Targets | Potassium Voltage Gated Channel Subfamily KQT Member 2, Potassium Voltage Gated Channel Subfamily KQT Member 3, Glutamate Ionotropic Receptor NMDA Type Subunit, Calcium Activated Potassium Channel, Neurotrophic Factor, and Voltage Dependent L Type Calcium Channel |
Key Mechanisms of Action | Potassium Voltage Gated Channel Subfamily KQT Member 2 Activator, Potassium Voltage Gated Channel Subfamily KQT Member 3 Activator, Glutamate Ionotropic Receptor NMDA Type Subunit Antagonist, Neurotrophic Factor Activator, and Voltage Dependent L Type Calcium Channel Blocker |
Key Routes of Administration | Intratympanic, Oral, and Topical |
Key Molecule Types | Small Molecule |
Major Companies | Gateway Biotechnology Inc, Altamira Therapeutics Ltd, AudioCure Pharma GmbH, Cognosetta Inc, Knopp Biosciences LLC, Otonomy Inc, and Sensorion SA |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Tinnitus
- The pipeline guide reviews pipeline therapeutics for Tinnitus by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Tinnitus therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Tinnitus therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Tinnitus
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Tinnitus
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Tinnitus pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
AudioCure Pharma GmbH
Cognosetta Inc
Gateway Biotechnology Inc
Knopp Biosciences LLC
Otonomy Inc
Sensorion SA
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Tinnitus pipeline drug market?
In the Tinnitus pipeline drugs market the key targets are Potassium Voltage Gated Channel Subfamily KQT Member 2, Potassium Voltage Gated Channel Subfamily KQT Member 3, Glutamate Ionotropic Receptor NMDA Type Subunit, Calcium Activated Potassium Channel, Neurotrophic Factor, and Voltage Dependent L Type Calcium Channel.
-
What are the key mechanisms of action in the Tinnitus pipeline drugs market?
In the Tinnitus pipeline drugs market the key mechanisms of action are Potassium Voltage Gated Channel Subfamily KQT Member 2 Activator, Potassium Voltage Gated Channel Subfamily KQT Member 3 Activator, Glutamate Ionotropic Receptor NMDA Type Subunit Antagonist, Neurotrophic Factor Activator, and Voltage Dependent L Type Calcium Channel Blocker.
-
What are the key routes of administration in the Tinnitus pipeline drugs market?
The key routes of administration in the Tinnitus pipeline drug market are Intratympanic, Oral, and Topical. Intratympanic has the maximum number of pipeline products.
-
What are the key molecule types in the Tinnitus pipeline drugs market?
The key molecule type in the Tinnitus pipeline drug market is Small Molecule.
-
What are the major companies in the Tinnitus pipeline drugs market?
In the Tinnitus pipeline drugs market the major companies are Gateway Biotechnology Inc, Altamira Therapeutics Ltd, AudioCure Pharma GmbH, Cognosetta Inc, Knopp Biosciences LLC, Otonomy Inc, and Sensorion SA.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.